Product Information
URO-PAIN 95 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1328 per EA under NDC 57237033103. Its NADAC has been published 104 times since Jul 3, 2024.
Strength
95 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237033103
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PHENAZOPYRIDINE HYDROCHLORIDEApproval Type
Unapproved
On Market Since
12/6/2023
Price Statistics
The NADAC for URO-PAIN 95 MG TABLET has been published 104 times since Jul 3, 2024, and over the history we have for it it has risen 11.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1328 per EA |
|---|---|
| All-time high | $0.1368 (Apr 15, 2026) |
| All-time low | $0.1184 (Sep 18, 2024) |
| 52-week high | $0.1368 |
| 52-week low | $0.1264 |
| Median price | $0.1264 |
| Average price | $0.1263 |
| Largest weekly change | -4.1% (Sep 18, 2024) |
| Weeks tracked | 104 |
| Tracking since | Jul 3, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Phenazopyridine Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of URO-PAIN 95 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for URO-PAIN 95 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.1328 per EA (NDC 57237033103), effective Jun 24, 2026.
How has the price of URO-PAIN 95 MG TABLET changed over time?
Over the history we have for it, the NADAC for URO-PAIN 95 MG TABLET has risen 11.5%. It has been tracked across 104 weekly CMS publications since Jul 3, 2024.
What are the highest and lowest recorded NADAC prices for URO-PAIN 95 MG TABLET?
Since Jul 3, 2024, the NADAC for URO-PAIN 95 MG TABLET has ranged from a low of $0.1184 (Sep 18, 2024) to a high of $0.1368 (Apr 15, 2026), with a median of $0.1264 per EA.
Are there cheaper alternatives to URO-PAIN 95 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of URO-PAIN 95 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures URO-PAIN 95 MG TABLET?
URO-PAIN 95 MG TABLET (NDC 57237033103) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification